The AI-driven rare disease patient finder market is poised for strong growth, driven by genomic sequencing, EHR utilization, ...

An analysis of a German multicentre study reveals that women are more likely than men to receive inappropriate diagnostic ...

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such ...

Mayo Clinic’s data platform is redefining how fast care can evolve — and how far high-quality care can reach. The Rochester, Minn.-based health system launched Mayo Clinic Platform in 2019 to extend ...

ROSA ® Knee with OptimiZe ™ Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and ...

Beacon Biosignals has secured $86m in a Series B funding round aimed at expanding its neurodiagnostic dataset and furthering ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q3 2025 Earnings Call Transcript November 13, 2025 ...

Clinical Data—SIMPLIFY Study -- Updated analysis increased Gallery's PPV in symptomatic patients to 84.2% after long-term ...

CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...

At 2 years, Black and white patients who received Lucentis for the treatment of diabetic macular edema achieved similar ...

State of Washington plans to invest in providers’ data infrastructure to enhance population health analytics, quality ...